Constipation and Gut Transit in DMD Patients

Children's Hospital Medical Center, Cincinnati8 enrolled

Overview

In this research study the investigators want to screen Duchenne Muscular Dystrophy (DMD) patients for signs and symptoms of constipation in patients over 18. The investigators hypothesized: * DMD patients have a high prevalence of constipation than in the general population. * Prevalence of constipation will increase with age and with worsening functional status.

The following procedures will take place during the study. Constipation Assessment: * The patient will be asked to complete a questionnaire about any symptoms of constipation. * A physician from the study team will perform an abdominal physical exam * The patient will have routine x-rays that monitor for spine compression fractures. These films will also be used to assess stool content. Clinical Information The following information will also be collected during the clinic visit ; * Age at diagnosis and genetic mutation * Age at loss of ambulation if applicable * Medications * Functional status

Study Type

OBSERVATIONAL

Enrollment

Conditions

Constipation DMD

Interventions

SmartPill ingestionDEVICE

The participant would ingest the SmartPill and wear the data receiver for up to 5 days.

Eligibility

Sex: MALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with a diagnosis of Duchenne Muscular Dystrophy (based on clinical presentation and verified by compatible muscle biopsy or known dystrophin gene mutation). * Age greater than or equal to 18 years old Exclusion Criteria: * None

Locations (1)

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

Outcomes

Primary Outcomes

GI transit times

Gi transit times will be computed by an investigator.

Time frame: up to 5 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.